Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 28.6% – Time to Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s share price shot up 28.6% during mid-day trading on Monday . The company traded as high as C$0.21 and last traded at C$0.18. 1,188,155 shares changed hands during mid-day trading, an increase of 253% from the average session volume of 336,778 shares. The stock had previously closed at C$0.14.

Voyageur Pharmaceuticals Price Performance

The company has a market capitalization of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The firm’s 50 day moving average price is C$0.08 and its two-hundred day moving average price is C$0.06. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.